Yunde Xiao

USPTO Granted Patents = 8 (Patent Applications = 10)

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

Catalyst Biosciences, Inc.

Years Active: 2014-2020

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10716770 - Nicotinic receptor non-competitive antagonists (2020-07-21),

2. 10258582 - Nicotinic receptor non-competitive antagonists (2019-04-16),

3. 9580434 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2017-02-28),

4. 9532974 - Nicotinic receptor non-competitive antagonists (2017-01-03),

5. 8921410 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-12-30),

6. 8859609 - Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes (2014-10-14),

7. 8809397 - Nicotinic receptor non-competitive antagonists (2014-08-19),

8. 8802694 - 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands (2014-08-12),

Title: Innovations and Contributions of Inventor Yunde Xiao

Introduction

Yunde Xiao is a prominent inventor based in Clemmons, North Carolina, recognized for his significant contributions to the field of pharmacology through his innovative research. With a total of 8 patents to his name, Xiao has made notable advancements in understanding and modulating nicotinic receptors, which play a crucial role in various neurological processes.

Latest Patents

Yunde Xiao’s latest patents focus on nicotinic receptor non-competitive antagonists. The first invention pertains to compounds that modulate nicotinic receptors as non-competitive antagonists, methods for their use, and their pharmaceutical compositions. The second patent further expands on this subject by detailing compounds that not only modulate these receptors as antagonists but also provides insights on synthesis methods, usage, and pharmaceutical formulations. These inventions contribute valuable knowledge towards developing new therapeutic strategies.

Career Highlights

Throughout his career, Yunde Xiao has worked with esteemed organizations such as Targacept, Inc. and Catalyst Biosciences, Inc. His experience in these companies allowed him to translate innovative scientific concepts into patentable technologies. His dedication to research and development in pharmacology is evident through his advancements in drug development, particularly in relation to nicotinic receptors.

Collaborations

In his professional journey, Yunde Xiao has collaborated with notable colleagues, including Srinivasa Rao Akireddy and Matt S. Melvin. These collaborations have fostered a dynamic exchange of ideas and enhanced the scope of research in the field of biotechnology and pharmacology.

Conclusion

Yunde Xiao's contributions to the field of pharmacology through his patents and collaborative efforts have had a significant impact on the understanding and modulation of nicotinic receptors. His work continues to inspire advancements in therapeutic solutions that could improve patient outcomes in various neurological conditions.

This text is generated by artificial intelligence and may not be accurate.